Article Details
Retrieved on: 2021-08-09 02:03:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The first patient in Race Oncology's (RAC) Phase 1b/2 acute myeloid leukaemia (AML) trial in Israel has been dosed with a novel treatment; The trial is ...
Article found on: themarketherald.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here